The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice. 2011

Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
Department of Immunology, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA. Ronald.P.Gladue@Pfizer.com

CD40 is a member of the TNF family of receptors that has been shown to play a crucial role in enhancing dendritic cell activity and fostering anti-tumor immune responses. In this study, we demonstrate the in vitro properties and in vivo efficacious activity of the CD40 agonist antibody, CP-870,893. CP-870,893 is a fully human, IgG2 antibody that selectively interacts with CD40 at a site distinct from its ligand-binding region with a KD of 0.4 nM. It enhances the expression of MHC class II, CD54, CD86, and CD23 on human B cells in vitro. CP-870,893 also enhances dendritic cell activity as evidenced by cytokine secretion (IL-12, IL-23, IL-8), the upregulation of CD86 and CD83, and the ability to prime T cells to secrete IFNγ. In SCID-beige mice, a single parenteral injection of CP-870,893 was therapeutically effective against several CD40(pos) human tumors (B-cell lymphoma, breast, colon, and prostate) indicating direct effects on tumor cell survival and/or growth. When mice were co-implanted with human T cells and dendritic cells, the activity of CP-870,893 against CD40(pos) tumors increased, and efficacy was also observed against CD40(neg) and CD40(low) tumors demonstrating the ability of CP-870,893 to enhance anti-tumor immune function in vivo. These studies suggest that CP-870,893 has the potential to be efficacious against a wide range of tumor types through both direct and immune-mediated effects.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
March 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
October 2010, Journal of immunotherapy (Hagerstown, Md. : 1997),
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
November 2009, Journal of translational medicine,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
January 2013, Oncoimmunology,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
June 2010, Scandinavian journal of gastroenterology,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
August 1996, Seminars in immunology,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
November 2013, Clinical cancer research : an official journal of the American Association for Cancer Research,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
July 1993, Human antibodies and hybridomas,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
July 1993, Human antibodies and hybridomas,
Ronald P Gladue, and Timothy Paradis, and Susan H Cole, and Carol Donovan, and Robin Nelson, and Robbin Alpert, and Joe Gardner, and Ed Natoli, and Eileen Elliott, and Richard Shepard, and Vahe Bedian
May 1992, AIDS research and human retroviruses,
Copied contents to your clipboard!